HSBC Holdings’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-519,779
Closed -$15.4M 3291
2023
Q4
$15.4M Buy
+519,779
New +$10.4M 0.01% 749
2021
Q3
Sell
-11,498
Closed -$76K 3208
2021
Q2
$76K Buy
+11,498
New +$80.2K ﹤0.01% 2869
2021
Q1
Sell
-16,425
Closed -$107K 3216
2020
Q4
$107K Buy
+16,425
New +$95.8K ﹤0.01% 2943
2020
Q3
Sell
-10,708
Closed -$49K 2905
2020
Q2
$49K Sell
10,708
-606
-5% -$2.58K ﹤0.01% 2577
2020
Q1
$39K Sell
11,314
-4,688
-29% -$20.5K ﹤0.01% 2577
2019
Q4
$82K Buy
16,002
+493
+3% +$1.67K ﹤0.01% 2945
2019
Q3
$38K Buy
+15,509
New +$41.2K ﹤0.01% 3028
2019
Q2
Sell
-10,400
Closed -$28K 2898
2019
Q1
$28K Buy
+10,400
New +$45K ﹤0.01% 2672
2017
Q1
Sell
-14,511
Closed -$30K 2664
2016
Q4
$30K Buy
+14,511
New +$29.1K ﹤0.01% 2690

Other funds holding IMGN

HSBC Holdings's IMGN Position: Q1 2024 in Review

HSBC Holdings sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 519,779 shares — an estimated $15.4M sold.

HSBC Holdings first reported a position in IMGN in Q4 2016 and held it in 9 quarters. The position peaked at $15.4M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • HSBC Holdings reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • HSBC Holdings sold 519,779 Immunogen Inc shares in Q1 2024, an estimated $15.4M.
  • HSBC Holdings first reported a position in Immunogen Inc in Q4 2016 and held it in 9 quarters.
  • HSBC Holdings's Immunogen Inc position peaked at $15.4M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on HSBC Holdings's 13F filing for Q1 2024, filed 15 May 2024.